Arrowhead Pharmaceuticals celebrates FDA approval for new rare disease therapy
Arrowhead Pharmaceuticals has achieved a significant milestone with the FDA approval of its new therapy designed to lower triglycerides for adults suffering from Familial Chylomicronemia Syndrome ...